Katholisches Klinikum Koblenz
Koblenz, 56073, Germany
NCT Number: NCT04489394
Prospective study, not randomised, non-interventional, monocentric, investigating an intended patient cohort of 60 patients already operated on the cervical spine due to degenerative disc disease of the cervical spine down to the first thoracolumbar VBR (C2-T1), who received a Quintex plate for stabilisation
Looking for future studies?
Notify MeAll sexes
Observational
Koblenz, 56073, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One retrospective visit, between one and approx. five years post-op.
The NDI is designed to measure neck-specific disability. The questionnaire has 10 items to measure patient-reported disability secondary to neck pain and activities of daily living including personal care, lifting, reading, headaches, concentration, work status, driving, sleeping and recreation and patients rate their status from 0 (best) to 5 (worst imaginable). Individual item responses are summed to a total score, where 0 points indicate no activity limitations and 50 points indicate complete activity limitation.
Time frame: One retrospective visit, between one and approx. five years post-op.
Visual analogue scale for pain: The visual analogue scale (VAS) is a scale used to determine the pain intensity experienced by individuals. It consists of a line, approximately 10-15 cm in length, with the left side signifying no pain with a smiling face image and the right side signifying the worst pain ever with a frowning face image.
Time frame: One retrospective visit, between one and approx. five years post-op.
Patient satisfaction with Outcome of surgery documented in two aspects: is the Patient satisfied (four Point scale:
very satisfied, satisfied, unsatisfied, very unsatisfied) and would the Patient like to undergo surgery again (yes, no, not willing to say)
Time frame: One retrospective visit, between one and approx. five years post-op.
The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/ depression. Each dimension has 5 levels: no problems, slight problems, moderate problems, severe problems and extreme problems. The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions. This decision results in a 1-digit number that expresses the level selected for that dimension. The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
Time frame: One retrospective visit, between one and approx. five years post-op.
Bazaz score: The Bazaz Dysphagia Score is one criterion used to define dysphagia; it classifies dysphagia as severe, moderate, mild, or none
Time frame: One retrospective visit, between one and approx. five years post-op.
Adverse Events and Serious Adverse Events, reoperations and revisions rates
Time frame: One retrospective visit, between one and approx. five years post-op.
The patient's Need for Pain Medication is measured by the WHO (World Health Organization) analgesic ladder
Time frame: One retrospective visit, between one and approx. five years post-op.
Radiologically: Fusion status, plate position, pot. migration of screws and plate, radiolucent lines
Aesculap AG
Industry
Prospective Follow-up Study of the Aesculap Quintex® Anterior Cervical Plating System After a Minimum of One Year
Acronym: Quintex
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03956537
Bone Diseases, Central Nervous System Diseases
Sande, Germany
View Trial DetailsNCT02558621
Bone Diseases, Degenerative Disc Disease
Genolier, Canton of Vaud, Switzerland
View Trial DetailsNCT03425682
Bone Diseases, Cervical Spondylosis
San Diego, California, United States
View Trial DetailsNCT03077204
Bone Diseases, Congenital Abnormalities
Austin, Texas, United States
View Trial Details